These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 150828)

  • 1. [State of renal structure and function in nephrotoxic nephritis treated with uroplasmin].
    Monastyrskiĭ VA; Ambarova LI; Beshleĭ VI; Stasiuk NS
    Arkh Patol; 1978; 40(5):26-31. PubMed ID: 150828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [State of the thrombin-plasmin system in nephrotoxic nephritis treated with heparin, urokinase, and uroplasmin].
    Monastyrskiĭ VA; Ambarova LI
    Arkh Patol; 1980; 42(1):17-22. PubMed ID: 6445726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Functional state of the kidneys in experimental immune nephritis during the use of heparin, urokinase and uroplasmin].
    Monastyrskiĭ VA; Ambarova LI
    Urol Nefrol (Mosk); 1977; (4):23-5. PubMed ID: 143102
    [No Abstract]   [Full Text] [Related]  

  • 4. Tissue plasminogen activator therapy of rabbit nephrotoxic nephritis.
    Zoja C; Corna D; Macconi D; Zilio P; Bertani T; Remuzzi G
    Lab Invest; 1990 Jan; 62(1):34-40. PubMed ID: 1688634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative effects of ancrod, urokinase and heparin on intraglomerular coagulation induced by progressive Masugi nephritis (author's transl)].
    Fujioka M
    Nihon Jinzo Gakkai Shi; 1980 Aug; 22(8):1113-24. PubMed ID: 7012408
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of urokinase on renal structure and function in experimental immune nephritis].
    Monastyrskiĭ VA; Abramova LI; Stasiuk NS; Beshleĭ VI
    Patol Fiziol Eksp Ter; 1979; (4):65-6. PubMed ID: 481925
    [No Abstract]   [Full Text] [Related]  

  • 7. [Expediency of the use of uroplasmin in clinical practice].
    Skipetrov VP; Potapkina N; Chernyshev V; Shuvalov V
    Vrach Delo; 1974 Jan; (1):48-50. PubMed ID: 4283231
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative effects of heparin, urokinase, and ancrod on intraglomerular coagulation induced in progressive Masugi nephritis.
    Dohi K; Fujioka M; Nakamoto Y
    Acta Pathol Jpn; 1982 Nov; 32(6):1047-52. PubMed ID: 6760667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ancrod and rtPA on fibrin accumulation, glomerular inflammation and renal function in nephrotoxic nephritis.
    Mathieson PW; Thiru S; Peters DK; Oliveira DB
    Int J Exp Pathol; 1991 Dec; 72(6):679-93. PubMed ID: 1768613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Masugi nephritis: the renal lesion and the coagulation processes.
    Borrero J; Todd ME; Becker CG; Becker EL
    Clin Nephrol; 1972; 1(2):86-93. PubMed ID: 4669792
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fibrin deposits in Masugi nephritis and effects of urokinase, non-steroidal anti-inflammatory agents, anti-inflammatory enzymes and prostaglandins].
    Sugizaki T
    Nihon Jinzo Gakkai Shi; 1983 Jul; 25(7):836-8. PubMed ID: 6663853
    [No Abstract]   [Full Text] [Related]  

  • 12. [A role of fibrin deposits in the development of rabbit Masugi nephritis and effect of urokinase on the experimental glomerulonephritis (author's transl)].
    Akiba T; Tanaka K
    Nihon Jinzo Gakkai Shi; 1982 Feb; 24(2):125-38. PubMed ID: 7047822
    [No Abstract]   [Full Text] [Related]  

  • 13. Cellular aspects of rabbit Masugi nephritis. III. Mesangial changes.
    Kondo Y; Shigematsu H; Okabayashi A
    Lab Invest; 1976 Apr; 34(4):363-71. PubMed ID: 1263440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The origin of glomerular crescents in experimental nephrotoxic serum nephritis in the rabbit.
    Cattell V; Jamieson SW
    Lab Invest; 1978 Dec; 39(6):584-90. PubMed ID: 368429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quantitative evaluation of anticoagulants in experimental nephrotoxic nephritis.
    Thomson NM; Simpson IJ; Peters DK
    Clin Exp Immunol; 1975 Feb; 19(2):301-8. PubMed ID: 1212801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
    Zoja C; Corna D; Bruzzi I; Foglieni C; Bertani T; Remuzzi G; Benigni A
    Exp Nephrol; 1996; 4(4):213-21. PubMed ID: 8983642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose local kidney irradiation inhibits progression of experimental crescentic nephritis by promoting apoptosis.
    Liu D; Nazneen A; Taguchi T; Razzaque MS
    Am J Nephrol; 2008; 28(4):555-68. PubMed ID: 18239382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of defibrination on macrophage participation in rabbit nephrotoxic nephritis: studies using glomerular culture and electronmicroscopy.
    Holdsworth SR; Thomson NM; Glasgow EF; Atkins RC
    Clin Exp Immunol; 1979 Jul; 37(1):38-43. PubMed ID: 487657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue-type plasminogen activator and its inhibitor in human glomerulonephritis.
    Aya N; Yoshioka K; Murakami K; Hino S; Okada K; Matsuo O; Maki S
    J Pathol; 1992 Mar; 166(3):289-95. PubMed ID: 1381427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Origin of glomerular crescents in rabbit nephrotoxic nephritis.
    Clarke BE; Ham KN; Tange JD; Ryan GB
    J Pathol; 1983 Mar; 139(3):247-58. PubMed ID: 6187908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.